US Stem Cell Inc (USRM)

[andyshow]

Bioheart Announces Expansion Of Clinical Study For Degenerative Disc Disease
Read more at http://www.stockhouse.com/news/press-releases/2014/11/17/bioheart-announces-expansion-of-clinical-study-for-degenerative-disc-disease#KtfADV0JRf81bJIv.99


Sunrise, FL / Accesswire / November 17, 2014 / Bioheart, Inc. (BHRT.OB), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will expand to a second clinical site to enroll patients in the study for degenerative disc disease (DDD). The study will enroll up to 100 patients to determine the safety and efficacy of adipose derived stem cells or AdipoCell(TM) in patients with DDD.

Robert Silbert, MD of Physical Medicine/ Rehab Associates in Indianapolis, Indiana is the principal investigator for the study and has been enrolling patients for approximately 6 months. Julian Robert Gershon Jr., DO, FAOASM, ABAARM and the team at Aspen Institute for Antiaging & Regenerative Medicine will now enroll patients at the center in Aspen, CO.

Bioheart has initiated this new study for DDD which will include a randomized control arm. The study has been reviewed and approved by the Institutional Review Board (IRB) of the International Cellular Medicine Society (ICMS). The ICMS IRB is committed to providing peer review of proposed studies of cell-based medical therapies based upon appropriate clinical translation, patient care and sa


Read more at http://www.stockhouse.com/news/press-releases/2014/11/17/bioheart-announces-expansion-of-clinical-study-for-degenerative-disc-disease#KtfADV0JRf81bJIv.99